Aion Therapeutic Inc.

OTC: ANTCF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, ONReports USD

#967 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 24

v0.1 · 5/100 weight · pillars only

↑ disclosure history, Piotroski F · ↓ return on assets, balance-sheet leverage

Methodology →

Revenue TTM

$1.1M

Rev growth YoY (TTM)

+547.6%

Net income (FY)

-$4.7M

Employees

Market cap

$2.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$272.1k367.5k CAD2024

Net income-$4.7M-6.3M CAD2024

Operating income-$882.0k-1.2M CAD2024

Total assets$511.3k702.9k CAD2024

Liabilities$3.3M4.6M CAD2024

Equity-$2.8M-3.9M CAD2024

Revenue trend

FY2017 – FY2024 · USD

FY17

FY18

FY19

FY20

FY21

FY22

FY23

$272.1k

FY24

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Aion Therapeutic Inc. booked $272.1k in FY2024 revenue — among the slowest-growing Healthcare companies we track, at a -1710.9% net margin.

Peers · Healthcare

Therma Bright Inc.22D Shuttle Pharmaceuticals Holdings, Inc.——Vycor Medical, Inc.56C Sonoma Pharmaceuticals, Inc.59C

Key facts

CEOJohn Graham Simmonds Jr.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, ON

ExchangeOTC: ANTCF

Employees5

IPO date2021-04-21

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.